Biotech & pharma
B cells produce antibodies 'when danger calls, but not when it whispers,' scientists report
20 May 2014
Cancer's potential on-off switch
19 May 2014
Harvard researchers use herpes virus to fight brain tumours
19 May 2014
Researchers have developed a new way to fight brain tumours by trapping oncolytic virus-loaded stem cells in a gel and then applying it directly to the malignancy
Patient stem cells used to make 'heart disease-on-a-chip'
17 May 2014
Harvard scientists have merged stem cell and 'organ-on-a-chip' technologies to grow, for the first time, functioning human heart tissue carrying an inherited cardiovascular disease
Study helps unravel the tangled origin of ALS
16 May 2014
Scientists reveal structural secrets of enzyme used to make popular anti-cholesterol drug
14 May 2014
10-year study shows 'Lethal Factor' could be X-factor for new anthrax vaccine
03 May 2014
Researchers have identified a section of the anthrax toxin Lethal Factor that could help produce a more effective vaccine
Fear of math? study finds some genetic factors
29 Apr 2014
New method to analyse how cancer cells die
26 Apr 2014
Skin layer grown in lab could replace animal testing
26 Apr 2014
The new epidermis, grown from human pluripotent stem cells, offers a cost-effective alternative lab model for testing drugs and cosmetics
Researchers develop lab grown skin
26 Apr 2014
Genetic legacy from the Ottoman Empire: single mutation causes rare brain disorder
By By Bill Hathaway | 25 Apr 2014
In the 'slime jungle' height matters
24 Apr 2014
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
